Kisqali 600 MG daily dose UU 63S
Ended Awarded
- Contract number
- SPE2DR26FW3F4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,280
Award facts
- Contract value 100% obligated
- $12,280.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $12,280 delivery order to Amerisourcebergen Drug Corp on June 29, 2026, for KISQALI 600 mg daily dose tablets (63 count) under a firm fixed-price structure. Ultimate completion is scheduled for July 21, 2026. Place of performance is Conshohocken, PA. This order is issued under a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical supply to federal healthcare systems. No set-aside was used.
Quick answers
Who was awarded contract SPE2DR26FW3F4?
SPE2DR26FW3F4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 29, 2026.
How much is contract SPE2DR26FW3F4 worth?
The government has obligated $12,280 on SPE2DR26FW3F4.
Is contract SPE2DR26FW3F4 an order under another contract?
Yes. SPE2DR26FW3F4 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FW3F4 competed?
The extent of competition for SPE2DR26FW3F4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award